October 29, 2025 2:51 am
Published by Diana Dugas
Prof. Andrew Scott leads the Tumour Targeting Laboratory at the Olivia Newton-John Cancer Research Institute, is the co-Director of the Centre for Research Excellence in Brain Cancer, is the Director of the Department of Molecular Imaging and Therapy, Austin Health, and holds Professorial positions at La Trobe University and The University of Melbourne. Andrew’s clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer (particularly with monoclonal antibodies), molecular imaging in oncology, and global advocacy... Read More
October 29, 2025 2:51 am
Published by Diana Dugas
Bronwyn Capanna recently retired as the Executive Director of Accord Australasia, the peak body representing the hygiene, personal care and specialty products industry in Australia. Commencing initially with a degree in pharmacy, during her career she has held senior positions in both the not-for-profit and private sectors spanning the healthcare, chemicals and related agriculture/veterinary medicines sectors. She has also held Ministerial appointed roles within these sectors and been actively involved in the development and implementation of government and industry policy... Read More
October 29, 2025 2:51 am
Published by Diana Dugas
Dr. Ivan Williams is a medical physicist, certified and registered, in the field of Radiation Oncology Medical Physics with the Australian College of Physical Scientists and Engineers in Medicine. Ivan has nearly thirty years’ experience in the field, evenly divided between clinical practice and government regulatory activities. Across his clinical work, Ivan has been deeply involved with the evaluation of long term impact of radiation exposure, the accuracy of dose calculation and measurement, and how to optimise the therapeutic outcome... Read More
October 29, 2025 2:51 am
Published by Diana Dugas
Prior to several years in private consulting, Dr. Chris Teleha had been at Janssen R&D, part of the family of companies of Johnson & Johnson (J&J) since 2003 and became Scientific Director R&D in 2012. There he contributed to a wide range of research projects, including process development for important candidates in the pipeline. Dr Teleha was also an Associate Director at DuPont Pharmaceuticals, later acquired by Bristol-Myers Squibb, where he became a Director. Chris’ very recent retirement provided the ITTC... Read More
October 29, 2025 2:51 am
Published by Diana Dugas
Mr Robert Klupacs was appointed Chief Executive Officer of the Bionics Institute on 1 May 2017. He has over 39 years of international corporate experience in technology development, mainly in the fields of medical technologies and biotechnology, with a particular focus on healthcare. Robert is scientifically trained in pharmacology and biochemistry. He is also an Australian-registered patent attorney with extensive experience in private and publicly traded companies as well as academia. Robert has been involved in the successful commercialisation of... Read More
October 29, 2025 2:50 am
Published by Diana Dugas
Dr Kathie McGregor has over 25 years of experience in research, IP, and commercialisation strategy at CSIRO, with a focus on fostering innovation, managing high-stake projects, and leading teams towards groundbreaking technology achievements. Kathie is currently a Research Director at CSIRO Manufacturing, with specific responsibility for the Advanced Materials and Processing Program, where she oversees a portfolio of strategic science and commercial projects, as well as manages a team of over 160 staff and affiliates. The program focuses on developing... Read More
October 29, 2025 2:50 am
Published by Diana Dugas
In the Australia Day 2023 Honours, Dr. Helen Tope was invested as an Officer of the Order of Australia (AO) for her distinguished service to environmental protection, particularly of the ozone layer, through leadership, research and policy development. Helen has over thirty years’ experience in environmental policy development and scientific, technical, and analytical studies. Helen is currently Principal Consultant, Montreal Protocol and Climate Change, with her business, Planet Futures, providing technical advice on the management of ozone-depleting substances and their high... Read More
